Candel Therapeutics, Inc. ( CADL) - Stock Earnings
CADL Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -29.5 million USD | — USD |
| 2026Q1 | -8.9 million USD | — USD |
| 2026Q2 | -38.9 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
CADL Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -37.9 million USD | 31000 USD |
| 2024 | -55.2 million USD | — USD |
| 2025 | -38.2 million USD | — USD |
| 2026 Est. | — | — |
CADL
Price: $10.16
52 week price:
Earnings Per Share: -1.46 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 14500
Market Capitalization: 936.4 million